ChemoCentryx CCXI
$ 51.99
0.0%
Quarterly report 2022-Q2
added 08-08-2022
Country |
USA |
IPO year |
2012 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Thomas Schall |
Employees in the company |
82 |
Shares |
69.9 K |
Market Cap[1] |
$ 3.74 B |
EBITDA (LTM) |
$ -126 M |
P/E (LTM) |
-27.51 |
P/S (LTM) |
100.3 |
EPS (LTM) |
-1.89 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.